Kailera Therapeutics indicating open at $24, 50% above IPO pricing at $16

Investing.com Gold reports: Kailera Therapeutics indicating open at $24, 50% above IPO pricing at $16. Full body text was unavailable at ingest time, so this brief is based on headline context.